Company name
2022Founder
Iambic Therapeutics develops cancer medicines using physics-informed AI and automated experiments, connecting molecular design with predictions of how drugs behave in people.
All fundraising announcements are based on public sources. Please contact Cosign if you believe there are any discrepancies, or claim the profile to edit.
Data current as of November 10, 2025